Target Name: MIR103A1
NCBI ID: G406895
Review Report on MIR103A1 Target / Biomarker Content of Review Report on MIR103A1 Target / Biomarker
MIR103A1
Other Name(s): mir-103a-1 | MIR103-1 | hsa-mir-103a-1 | MIRN103-1 | hsa-miR-103a-1-5p | MicroRNA 103a-1 | microRNA 103a-1 | hsa-miR-103a-3p

MIR103A1: A Potential Drug Target for Various Diseases

MIR103A1, also known as mir-103a-1, is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the Mir gene family, which encodes for a family of cytoskeleton-associated proteins that play important roles in cell signaling and mechanics.

MIR103A1 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has also been implicated in several diseases, including neurofibromatosis, a genetic disorder that causes tumors, and neuroimaging studies that suggest the involvement of this protein in various neurological conditions.

One of the key functions of MIR103A1 is its role in the regulation of cell division and cell signaling. It is a transcription factor that has been shown to play a role in the regulation of cell proliferation and differentiation, and it has been implicated in the development and progression of several diseases. For example, MIR103A1 has been shown to be involved in the development of neurofibromatosis, a genetic disorder that is characterized by the formation of tumors.

In addition to its role in cell signaling, MIR103A1 is also involved in the regulation of cell mechanics. It is a protein that is involved in the formation of actin filaments, which are important for maintaining the structural integrity of cells. This protein has also been shown to play a role in the regulation of cell migration and the maintenance of tissue structure, which are important for the proper functioning of various organs and tissues.

MIR103A1 has also been implicated in several other diseases and conditions, including neurodegenerative disorders, autoimmune disorders, and cancer. For example, MIR103A1 has been shown to be involved in the development and progression of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. It has also been implicated in the development and progression of several cancers, including breast, ovarian, and colorectal cancers.

Due to its involvement in several diseases and conditions, MIR103A1 has been identified as a potential drug target. Researchers are currently working to develop new treatments for MIR103A1-related diseases, including cancer, neurodegenerative disorders, and autoimmune disorders.

In conclusion, MIR103A1 is a protein that has been identified as a potential drug target due to its involvement in several cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to understand the full role of MIR103A1 in these diseases and to develop effective treatments.

Protein Name: MicroRNA 103a-1

The "MIR103A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR103A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272